1612854-17-7

Basic information

• Product Name: C₃₅H₄₂F₃N₅O₆S
• Synonyms: C₃₅H₄₂F₃N₅O₆S
• CAS NO: 1612854-17-7
• Molecular Weight: 717.81
• Mol File: 1612854-17-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₃₅H₄₂F₃N₅O₆S(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₅H₄₂F₃N₅O₆S(1612854-17-7)
• EPA Substance Registry System: C₃₅H₄₂F₃N₅O₆S(1612854-17-7)

Safety Data

• Hazardous Substances Data: 1612854-17-7(Hazardous Substances Data)

Upstream product

• 1228553-33-0 [(S)-2-methyl-1-((S)-2-{5-[4-(4,4,5,5 tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-1H-imidazol-2-yl}-pyrrolidine-1-carbonyl)-propyl]-carbamic acid methyl ester 
• 1612236-06-2 C₁₆H₁₇F₆NO₆S₂ 
• 1612236-05-1 C₁₄H₁₉NO₂ 
• 1612236-04-0 C₁₆H₂₃NO₂ 
• 1612236-03-9 C₁₆H₂₁NO₃ 
• 1228552-27-9 ((S)-1-{(S)-2-[5-(4-bromophenyl)-1H-imidazol-2-yl]pyrrolidine-1-carbonyl}-2-methylpropyl)carbamic acid methyl ester 
• 1007882-04-3 (S)-tert-butyl 2-(5-(4-bromophenyl)-1H-imidazol-2-yl)pyrrolidine-1-carboxylate 
• 52428-09-8 4,7-dimethoxyindan-1-one 
• 10538-49-5 3-(2,5-dimethoxyphenyl)propanoic acid 
• 93-02-7 2,5-dimethoxybenzaldehyde 

Downstream Products

• 1612854-18-8 C₅₄H₆₅N₉O₇ 

Relevant articles and documents

SPIRO RING COMPOUND AS HEPATITIS C VIRUS (HCV) INHIBITOR AND USES THEREOF FIELD OF THE INVENTION

A compound of formula (I) or a stereoisomer, a geometric isomer. a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof is provided, which can be used for treating HCV infection or a HCV disorder. Also a pharmaceutical composition comprising the compound and the use of the compound and the pharmaceutical composition thereof are provided, which can also be used for treating HCV infection or a HCV disorder.